Renin measurement

PreclinicalBiologic

UUniversity Hospital, Angers

Renin measurement is one of 20 biologic programs targeting Blood Pressure. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Blood PressureUnknown status

Blood PressurePreclinical

Unknown status

Competition

Competitive Landscape

29 competitors in Blood Pressure

#DrugCompanyPhaseTrials

Benicar

Novartis

Phase 3

2 2

Intropin

Pfizer

Preclinical

1 3

Isoproterenol Hydrochloride

Sanofi

Preclinical

1 4

Robinul

Jazz Pharmaceuticals

Preclinical

1 5

Carbocaine

Pfizer

Preclinical

1 6

Chirocaine

PPurdue Pharma LP

Preclinical

1 7

Ephedrine Sulfate

DDr. Reddys Laboratories, SA

Preclinical

1 8

Atropen

FFresenius Kabi Taiwan Ltd.

Preclinical

1 9

Pitressin

AAultman Health Foundation

Preclinical

1 10

Glypressin

MMallinckrodt

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Blood Pressure1 trial

Study of the Variations of the Blood Pressure After Nephrectomy for Renal Cancer (VAPANCR)

Unknown status·UUniversity Hospital, Angers·N/A·NCT03218319·200 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Renin measurement. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Renin measurement compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Renin measurement. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University Hospital, Angers company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Preclinical[1]
Company: UUniversity Hospital, Angers

Renin measurement

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Blood Pressure1 trial

References

Drug Info

Quick Facts

Related News